The authors proved that G3P supplementation can inhibit RSL3-induced ferroptosis in different cancer cell lines and that GPD2 deletion significantly sensitized cells to GPX4 inhibitors, and this was accompanied by increased mitochondrial lipid peroxidation. This evidence concerns the gene GPX4 and cancer.